Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BPH ENERGY LTD Capital/Financing Update 2007

Jul 15, 2007

64555_rns_2007-07-15_67ede391-7d27-4255-a44d-13500d96d6e9.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [134 x 60] intentionally omitted <==

16 July 2007

Companies Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam,

RE: EXERCISE OF BPHO OPTIONS

Further to the Appendix 3B lodged on 29 June 2007, the Company advises that final option exercise applications were accepted for a total of 3,318,228 BPHO options prior to expiry of these options on 30 June 2007. The Company received $663,646 from the conversion of the options.

Yours Sincerely

==> picture [120 x 43] intentionally omitted <==

David Breeze Managing Director

BioPharmica Limited ACN 95 912 002 PO Box 317, North Perth 6906, Western Australia 14 View Street, North Perth, Western Australia 6006 [email protected] www.biopharmica.com.au

T: +61 8 9328 8366 F: +61 8 9328 8733